SARS and MERS Inhibited by Ebola Drug

GEN Sounds of Science June 29, 2017A research team from Vanderbilt University, University of North Carolina, and Gilead Sciences has just released new findings in Science Translational Medicine describing how a new antiviral drug candidate inhibits a broad range of coronaviruses, including SARS and MERS.Link to artice: http://stm.sciencemag.org/content/9/396/eaal3653 Hosted on Acast. See acast.com/privacy for more information.